Skip to content
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
Investor news
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Press releases
In the news
Investor news
Videos
News archive
Homepage
Open navigation
Home
Technology
The platform
Artificial Intelligence
BioClick
Nobel Prize heritage
Biosolution phases
Scientific papers
Patents
Pipeline
Pipeline overview
NCT: Over-the-Counter
NCT: Pharma
Cannabinoids
Santalene
Become a partner
Investors
Stock information
Investor news
Email signup
Investor Relation Contacts
Governance
SEC Filings
Video
About
Leadership team
History
Jobs
Policies
Terms of Use
FCOI
Privacy Policy
Contact
News
Latest news
Press releases
In the news
Investor news
Videos
News archive
Posts in: press release
press release
investor
eXoZymes Reports Third Quarter 2026 Results and Provides Business Update at 5PM ET Today
November 19, 2026
press release
investor
eXoZymes to Host Third Quarter 2026 update Conference Call on Thursday, November 19, 2026
November 12, 2026
heltzen
press release
investor
CEO to discuss commercialization, key milestones, and potential catalysts in fireside chat with WTR
October 21, 2026
heltzen
press release
investor
eXoZymes Reports Second Quarter 2026 Results and Provides Business Update at 5PM ET today
August 20, 2026
press release
investor
science
perriman
NCT
eXoZymes' NCT process achieves 10-fold productivity increase, advancing beyond original commercial-scale economic targets
August 18, 2026
press release
investor
EXOZ to host Q2 2026 investor update on Aug 20 @ 5PM Eastern
August 11, 2026
heltzen
press release
science
eXoZymes selected for DoE’s Genesis Mission to advance AI-powered digital twins for cell-free biomanufacturing
July 23, 2026
heltzen
press release
investor
medicine
science
cannabinoids
korman
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug Discovery
June 24, 2026
press release
investor
eXoZymes Inc. Announces Closing of $6 Million Public Offering
June 17, 2026
press release
investor
eXoZymes Inc. Announces Pricing of Public Offering of Common Stock and Warrants
June 8, 2026
Previous page
Page 1 of 6
Next page